Shandong Lukang Pharmaceutical Group Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd. is one of the four major antibiotic production bases in China and the first large-scale joint-stock enterprise in the pharmaceutical industry in Shandong Province. Anti-Medicine A shares were listed on the Shanghai Stock Exchange in February 1997, stock code: 600789.

Lukang Pharmaceutical is a national large-scale first-class enterprise and a domestic pharmaceutical enterprise with the most complete range of GMP certifications. It is also the first in the country's western medicine system to pass ISO9001 quality system certification and ISO14001 environmental system certification. The "Lukang brand" trademark has been officially recognized as a well-known trademark in China by the Trademark Office of the State Administration for Industry and Commerce. It is one of the five internationally renowned brands that are focused on cultivating in Shandong Province. The company mainly produces and operates antibiotic APIs, semi-synthetic antibiotic APIs and related preparation products, pharmaceutical intermediates, etc. The company actively adjusts its product layout and optimizes its product structure. It has now formed three series of product chains with 6-APA, 7-ACA, and 7-ADCA as the mother core, achieving a successful leap from traditional antibiotic production to semi-synthetic antibiotic production. . As of December 31, 2006, the company's total assets reached 2.43 billion yuan.

Lukang Company normally produces more than 100 kinds of drugs. The company has formulated internal corporate control standards that are higher than the national pharmacopoeia standards and implements a "quality veto" system. With excellent quality and high reputation among the public, all products of Lukang Pharmaceutical have been rated as high-quality products at the provincial level or above. The pass rate of product market spot checks has been 100% for 18 consecutive years.

The God of life protects health. Lukang Pharmaceutical is based on the strategic goal of sustained and far-reaching development, holds high the green banner of the national pharmaceutical industry, gathers development momentum with technological innovation, management innovation, and marketing innovation, uses modern biotechnology as a means, and takes protecting the lives of patients as its own responsibility, and strives to People's health care services!